Enveric Biosciences, Inc.(ENVB)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2023-09-19 | PASQUALONE FRANK Director | Purchase | +1,000 | +100.00%1,000 | $2.14 | $2,140 | View SEC filing | |
| 2018-11-20 | Sikaria Lokesh 10% Owner | Sale | -100,000 | -2.50%3,900,000 | $0.30 | $29,550 | View SEC filing | |
| 2018-11-20 | Sikaria Chanda 10% Owner | Sale | -100,000 | -2.50%3,900,000 | $0.30 | $29,550 | View SEC filing | |
| 2018-11-20 | Lokesh Sikaria Trust Dated 12/14/2012 10% Owner | Sale | -100,000 | -2.50%3,900,000 | $0.30 | $29,550 | View SEC filing | |
| 2018-11-20 | Sikaria Family 2008 Revocable Trust Dated 02/28/2008 10% Owner | Sale | -100,000 | -2.50%3,900,000 | $0.30 | $29,550 | View SEC filing | |
| 2018-07-19 | Devanur Giri 10% Owner | Mixed | -404,357 | -18.67%1,761,989 | $1.97 | $894,696 | View SEC filing | |
| 2017-11-21 | Devanur Giri President & CEO | Purchase | +24,242 | +1.11%2,203,467 | $2.06 | $49,999 | View SEC filing | |
| 2017-11-21 | Eberwein Jeffrey E. Director, 10% Owner | Purchase | +200,000 | +6.96%3,072,592 | $2.06 | $412,500 | View SEC filing | |
| 2017-11-21 | Rai Dhruwa N Director | Purchase | +290,900 | +57.80%794,229 | $2.06 | $599,981 | View SEC filing | |
| 2017-10-31 | Eberwein Jeffrey E. Director, 10% Owner | Purchase | +3,803 | +37.63%13,910 | $6.50 | $24,719 | View SEC filing | |
| 2017-09-08 | Eberwein Jeffrey E. Director, 10% Owner | Purchase | +7,500 | +288.02%10,104 | $6.50 | $48,750 | View SEC filing | |
| 2017-08-23 | Eberwein Jeffrey E. Director, 10% Owner | Purchase | +2,604 | +100.00%2,604 | $6.50 | $16,924 | View SEC filing | |
| 2017-04-03 | Eberwein Jeffrey E. Director, 10% Owner | Purchase | +223 | +0.27%83,108 | $6.51 | $1,452 | View SEC filing | |
| 2017-02-14 | Eberwein Jeffrey E. Director, 10% Owner | Purchase | +434 | +0.53%82,795 | $6.51 | $2,825 | View SEC filing | |
| 2017-01-25 | Eberwein Jeffrey E. Director, 10% Owner | Purchase | +2,130 | +2.66%82,187 | $6.51 | $13,866 | View SEC filing | |
| 2017-01-20 | Eberwein Jeffrey E. Director, 10% Owner | Purchase | +10,000 | +14.30%79,933 | $6.51 | $65,100 | View SEC filing | |
| 2017-01-04 | Eberwein Jeffrey E. Director, 10% Owner | Purchase | +40 | +0.06%69,911 | $6.51 | $260 | View SEC filing | |
| 2016-12-30 | Eberwein Jeffrey E. Director, 10% Owner | Purchase | +1,506 | +2.20%69,871 | $6.51 | $9,804 | View SEC filing | |
| 2016-12-23 | Eberwein Jeffrey E. Director, 10% Owner | Purchase | +700 | +1.03%68,365 | $6.51 | $4,557 | View SEC filing | |
| 2016-12-02 | Eberwein Jeffrey E. Director, 10% Owner | Purchase | +808 | +1.21%67,663 | $6.51 | $5,260 | View SEC filing | |
| 2016-10-21 | Eberwein Jeffrey E. Director, 10% Owner | Purchase | +526 | +0.79%66,785 | $6.51 | $3,424 | View SEC filing | |
| 2016-09-28 | Eberwein Jeffrey E. Director, 10% Owner | Purchase | +183 | +0.28%66,234 | $6.51 | $1,191 | View SEC filing | |
| 2016-09-06 | Eberwein Jeffrey E. Director, 10% Owner | Purchase | +18,685 | +39.45%66,051 | $6.51 | $121,639 | View SEC filing | |
| 2016-08-31 | Eberwein Jeffrey E. Director, 10% Owner | Purchase | +1,094 | +2.36%47,366 | $6.51 | $7,122 | View SEC filing | |
| 2016-08-26 | Eberwein Jeffrey E. Director, 10% Owner | Purchase | +450 | +0.98%46,272 | $6.51 | $2,929 | View SEC filing |
1-25 of 61